UBS Group’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.6M Buy
2,512,285
+1,101,020
+78% +$33.6M 0.01% 1150
2025
Q4
$30.8M Buy
1,411,265
+217,760
+18% +$5.09M 0.01% 2150
2025
Q3
$27.2M Sell
1,193,505
-585,095
-33% -$11.8M ﹤0.01% 2231
2025
Q2
$29.2M Buy
1,778,600
+1,092,275
+159% +$18.5M 0.01% 1999
2025
Q1
$10.2M Buy
686,325
+86,681
+14% +$1.43M ﹤0.01% 3018
2024
Q4
$8.51M Buy
599,644
+369,815
+161% +$6.93M ﹤0.01% 3239
2024
Q3
$5.25M Buy
229,829
+48,395
+27% +$1.14M ﹤0.01% 3019
2024
Q2
$4.67M Buy
181,434
+36,836
+25% +$938K ﹤0.01% 2941
2024
Q1
$3.38M Sell
144,598
-12,474
-8% -$282K ﹤0.01% 3385
2023
Q4
$3.15M Sell
157,072
-1,491,355
-90% -$30.8M ﹤0.01% 3306
2023
Q3
$31M Sell
1,648,427
-536,694
-25% -$9.03M 0.01% 1153
2023
Q2
$31.7M Buy
2,185,121
+733,664
+51% +$11M 0.01% 1108
2023
Q1
$24M Buy
1,451,457
+1,241,540
+591% +$19.5M 0.01% 1250
2022
Q4
$2.55M Buy
209,917
+169,494
+419% +$2.18M ﹤0.01% 3148
2022
Q3
$442K Sell
40,423
-440
-1% -$4.82K ﹤0.01% 4447
2022
Q2
$362K Sell
40,863
-52,916
-56% -$479K ﹤0.01% 4506
2022
Q1
$825K Sell
93,779
-20,071
-18% -$159K ﹤0.01% 4296
2021
Q4
$805K Buy
113,850
+16,883
+17% +$135K ﹤0.01% 4576
2021
Q3
$908K Sell
96,967
-30,187
-24% -$239K ﹤0.01% 4273
2021
Q2
$1.14M Buy
127,154
+17,198
+16% +$138K ﹤0.01% 4068
2021
Q1
$786K Sell
109,956
-2,845
-3% -$19.6K ﹤0.01% 4487
2020
Q4
$702K Sell
112,801
-14,943
-12% -$96K ﹤0.01% 4309
2020
Q3
$831K Sell
127,744
-118,472
-48% -$908K ﹤0.01% 3776
2020
Q2
$1.72M Sell
246,216
-346,146
-58% -$2.94M ﹤0.01% 3017
2020
Q1
$5.69M Buy
592,362
+218,478
+58% +$2.04M ﹤0.01% 1820
2019
Q4
$4.81M Buy
373,884
+86,757
+30% +$945K ﹤0.01% 2638
2019
Q3
$2.61M Sell
287,127
-177,578
-38% -$1.43M ﹤0.01% 3041
2019
Q2
$3.72M Buy
464,705
+325,210
+233% +$2.59M ﹤0.01% 2575
2019
Q1
$901K Sell
139,495
-228,133
-62% -$1.36M ﹤0.01% 3668
2018
Q4
$2.03M Buy
367,628
+268,500
+271% +$1.75M ﹤0.01% 3023
2018
Q3
$576K Sell
99,128
-88,637
-47% -$468K ﹤0.01% 4315
2018
Q2
$1.1M Buy
187,765
+128,113
+215% +$646K ﹤0.01% 3711
2018
Q1
$264K Buy
59,652
+44,645
+297% +$200K ﹤0.01% 4600
2017
Q4
$68K Buy
15,007
+8,071
+116% +$45.1K ﹤0.01% 5609
2017
Q3
$42K Sell
6,936
-19,765
-74% -$111K ﹤0.01% 5909
2017
Q2
$153K Sell
26,701
-26,178
-50% -$161K ﹤0.01% 4916
2017
Q1
$357K Buy
52,879
+37,851
+252% +$264K ﹤0.01% 4271
2016
Q4
$107K Sell
15,028
-54,202
-78% -$401K ﹤0.01% 5244
2016
Q3
$496K Sell
69,230
-305,613
-82% -$2.36M ﹤0.01% 3927
2016
Q2
$2.95M Buy
374,843
+177,868
+90% +$1.46M ﹤0.01% 2443
2016
Q1
$1.65M Buy
196,975
+85,918
+77% +$830K ﹤0.01% 2848
2015
Q4
$1.66M Buy
111,057
+82,579
+290% +$1.26M ﹤0.01% 2971
2015
Q3
$383K Sell
28,478
-68,103
-71% -$914K ﹤0.01% 4123
2015
Q2
$1.18M Sell
96,581
-4,984
-5% -$66.5K ﹤0.01% 3432
2015
Q1
$1.14M Buy
101,565
+98,347
+3,056% +$1.37M ﹤0.01% 3463
2014
Q4
$40K Buy
+3,218
New +$26.2K ﹤0.01% 6761

Other funds holding FRO

UBS Group's FRO Position: Q1 2026 in Review

UBS Group increased its Frontline (FRO) stake by 78% in Q1 2026, buying an estimated $33.6M and bringing the position to 2,512,285 shares worth $87.6M. The position accounts for 0.01% of the portfolio, ranked #1150.

UBS Group first reported a position in FRO in Q4 2014 and has held it in 46 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

  • UBS Group held 2,512,285 shares of Frontline worth $87.6M as of Q1 2026.
  • UBS Group bought 1,101,020 Frontline shares in Q1 2026, an estimated $33.6M.
  • Frontline made up 0.01% of UBS Group's portfolio in Q1 2026, its #1150 holding.
  • UBS Group first reported a position in Frontline in Q4 2014 and has held it in 46 quarters since.
  • 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.